January 2026

ICO and IDIBELL lead an international study that guarantees the safety of a type of immunotherapy before transplantation

Bispecific antibodies are an immunotherapy that can be perfectly combined with bone marrow transplants in patients with lymphoma.

ICO and IDIBELL lead an international study that guarantees the safety of a type of immunotherapy before transplantation Read More »

The Viladecans Association Against Cancer allocates the money raised in 2025 to research against colorectal cancer

The Association made a donation of 47,870€ to IDIBELL, demonstrating once again its commitment to biomedical research.

The Viladecans Association Against Cancer allocates the money raised in 2025 to research against colorectal cancer Read More »

An international study confirms two equally effective treatment options for patients with advanced pancreatic neuroendocrine tumours

It is the first large-scale and well-controlled study that shows that chemotherapy works in this type of tumor, and is well tolerated when compared to a common treatment such as everolimus.

An international study confirms two equally effective treatment options for patients with advanced pancreatic neuroendocrine tumours Read More »

Scroll to Top